INTRODUCTION

NARCOLEPSY IS A DEBILITATING, LIFELONG DISORDER CHARACTERIZED BY EXCESSIVE DAYTIME SLEEPI-NESS AND REM SLEEP ABNORMALITIES INCLUDING CATAPLEXY, HYPNAGOGIC HALLUCINATIONS, AND SLEEP PARALYSIS. The International Classification of Sleep
Disorders 1 allows for a diagnosis of narcolepsy in patients without cataplexy; however, narcolepsy with clear-cut cataplexy constitutes a more etiologically homogenous, HLA-associated disease entitity. 2 An autosomal recessive form of narcolepsy in two canine models has been shown to be due to exon-skipping deletions of the hypocretin receptor 2 gene transcript. 3 In humans, loss of hypocretin-containing neurons appears to be a generally consistent feature of narcolepsy with unambiguous cataplexy. 4, 5 The etiology of human narcolepsy with cataplexy is thought to involve both genetic and environmental factors and a possible autoimmune-mediated degeneration of hypocretin (orexin) neurons. Evidence for environmental involvement includes the low rate of monozygotic twin concordance and the relatively infrequent familial occurences. 6, 7 Evidence for the involvement of the immune system includes a strong association between narcolepsy with clinically-typical or severe cataplexy and HLA genes, especially DQB1*0602. 2 Evidence that environmental factors may act during early development was provided in three recent studies showing unusual birth patterns in narcolepsy patients from the Northern hemisphere. [8] [9] [10] Okun et al. provided data suggestive of a March peak and September trough in 484 narcolepsy-cataplexy births. 8 In a subsequent report based on analyses of databases from clinics in the U.S., Canada, and France, Dauvilliers et al. found in a significant excess of births in March (11.9%) and a significant fall-off in births in September (5.6%) in 886 narcolepsy-cataplexy births (including 377 from the Okun et al initial sample). 9 Finally, Dahmen et al, studying 511 German narcoleptic patients, found a season of birth effect with a maximum between March and June and a minimum in September. 10 Seasonal birth patterns have been found for other CNS disorders such as Parkinson's disease 11 and schizophrenia 12 as well as for autoimmune disorders such as type 1 diabetes mellitus. 13 These patterns have been taken as evidence of exposure to a noxious event during early development. 14 The present paper provides further information about monthof-birth patterns in narcolepsy. The data were obtained from narcolepsy patients taking part in clinical trials assessing the safety and efficacy of modafinil for the treatment of excessive daytime sleepiness. This database provided an opportunity to further assess the replicability of the above-described birth pattern using a national multi-center U.S. sample. Analysis of the pattern was extended by examining the month-of-birth association in relation to the presence and severity of cataplexy. It is currently unknown whether a month-of-birth pattern will be found for patients without clear-cut cataplexy. Notably, the HLA DQB1*0602 association with narcolepsy, which is quite strong when cataplexy is moderate-to-severe and clinically typical, is also evident (though weaker) when cataplexy is mild or absent. 2 An additional purpose of this study was to assess whether the month-of-birth pattern is at all dependent on genetic susceptibility as indexed by positivi-ty for HLA-DQB1*0602. Finding that a month-of-birth effect is independent of genetic susceptibility would raise the possibility of separate etiological mechanisms and provide evidence of disease heterogeneity with possible diagnostic and treatment implications.
METHOD
Participants
Data were obtained from 239 male and 291 female narcolepsy patients (18-68 years of age) taking part in two successive multicenter clinical trials (studies 301 and 302) assessing the safety and efficacy of modafinil (Provigil ® ) in the treatment of excessive daytime sleepiness associated with narcolepsy. Of the 530 total patients, 273 were enrolled in study 301 (18 U.S. sleep centers) 15 and 257 were enrolled in study 302 (21 U.S. sleep centers). 16 The patients had a current diagnosis of narcolepsy using the criteria of the International Classification of Sleep Disorders 1 and based on clinical histories, nocturnal polysomnography, and a Multiple Sleep Latency Test. The entrance criteria for patients with cataplexy was a) sudden bilateral loss of postural muscle tone associated with intense emotion, b) mean MSLT sleep latency of ≤ 8 minutes, and c) ≥ 2 sleep-onset REM periods. The entrance criteria for patients without cataplexy was a) sleep paralysis, hypnagogic hallucinations, automatic behaviors, or disturbed major sleep episodes, b) mean MSLT sleep latency of ≤ 5 minutes, and c) ≥ 2 sleep-onset REM periods. The mean age of participants was 41.8 ± 13.3 at the time the trials were conducted, 45.1% were males, and 10.4% had a reported family history of narcolepsy-cataplexy (9.6% for patients with cataplexy and 13.8% for patients without cataplexy). Patients were black (14.5%), non-Hispanic white (81.8%), or other race (3.6%) by self-description. Of the 495 with HLA genotype data available, 68.3% were HLA-DQB1*0602 positive. The process followed in HLA typing of this sample is described in a previous study. 2 Analyses were also conducted according to untreated cataplexy severity using ratings based solely on individual clinical judgments at disease onset and at the time of enrollment in the study. At each time point, the patient was rated on a four-point scale of 0 (without cataplexy), 1 (mild cataplexy), 2 (moderate cataplexy), or 3 (severe cataplexy). These two ratings were added together to yield a scale with a seven-point range to increase the reliability of the rating. On this scale, "0" was taken to indicate no cataplexy (n = 94), a "1" or "2" to indicate mild cataplexy (n = 223), a "3" or "4" to indicate moderate cataplexy (n = 172), and a "5" or "6" to indicate severe cataplexy (n = 41). Patients with ratings of moderate-to-severe were considered more likely to have clinically-typical, clear-cut cataplexy. 2 
Analyses
The overall month of birth data were analyzed using χ 2 with 11 degrees of freedom by comparing the observed frequencies to the expected frequencies based on proportions obtained from the National Center for Health Statistics. 17 These proportions were derived from 150,889,983 recorded live births as part of the natality data from the Vital Statistics for the United States from . To analyze the percentages associated with individual months, χ 2 with 1 degree of freedom was calculated with the expected frequency corresponding to that month's particular value from the National Center of Health Statistics data. Odds ratios and the associated confidence intervals were also calculated for individual months by creating a control group of the same size as the patient group with birth months corresponding to the proportions obtained from the National Center of Health Statistics and comparing the risk of that particular month versus all other months. A hierarchical logistic regression was performed to assess the independence of and possible interaction between a March or September birth (yes/no) and HLA-DQB1*0602 status (positive/negative) as risk factors for narcolepsy with moderate-to-severe cataplexy. This analysis was performed by creating a control group of the same size as the patient group using the population values for a March or September birth as above and the average population value across ethnicities of 22.5% for HLA-DQB1*0602 status. 18 
RESULTS
The Analysis Of Only Those Patients With Cataplexy Replicates Previous Research
Examination of the month-of-birth distribution for all narcolepsy patients with cataplexy revealed a peak of 13.1% for March births and a trough of 6.2% for September births. The overall χ 2 analysis of the month-of-birth distribution for these patients relative to the general population was marginally significant (χ 2 11 = 18.6, p < .10). Because the March and September findings are in line with previous studies, analyses of those individual months vs. other months proceeded. The excess in March births was statistically significant (χ 2 1 = 13.4, p < .001). The September drop in births was marginally significant (χ 2 1 = 3.5, p < .10). The odds ratio for a March birth was 1.67 (95% CI = 1.08-2.60) and the odds ratio for a September birth was 0.69 (95% CI = 0.41-1.15). These percentages and odds ratios are very similar to the values previously reported (March: 11.85%, OR = 1.45; September: 5.64%, OR = 0.63). 9
The Association Between Month of Birth and Narcolepsy Varies With the Presence and Severity of Cataplexy
The increase in March births and the decrease in September births varied with ratings of cataplexy severity (Figure 1 ). The percentage of March births was close to the general population value of 8.3% when cataplexy was absent (severity rating of "0") or rated as mild (ratings of "1" and "2"). Higher cataplexy severity ratings ("4" through "6") were associated with systematically higher percentages of March births. September births showed a trend in the opposite direction. Collapsing the mild and moderate-to-severe ratings, a significant increase in March births and a significant decrease in September births was only seen when cataplexy was moderate-to-severe (Table 1) . Such moderating effects were not found for any other symptom of narcolepsy including sleepiness, hypnagogic hallucinations, sleep paralysis, and disturbed sleep.
Narcolepsy Patients with Moderate-to-Severe Cataplexy Born in March or September were Diagnosed at an Earlier Age than Patients Born in Other Months
Patients born in March or September were remarkably similar in symptoms and features when compared to patients born in any other month (Table 2) Table 2 were made using parametric or nonparametric tests depending on distributional characteristics. A .01 level of significance was adopted because of the large number of comparisons.
March Birth and HLA-DQB1*0602 are Independent Risk Factors for Narcolepsy with Moderate-to-Severe Cataplexy
The March surplus and September fall-off in births does not appear to depend on HLA-DQB1*0602 status. The percentage of March births was 17.8% (31 of 174 births) and 20.0% (5 of 25 births) for DQB1*0602 positive and negative patients, respectively. The percentage of September births was 4.6% (8 of 174 births) and 4.0% (1 of 25 births) for DQB1*0602 positive and negative patients, respectively. A summary of the hierarchical logistic regression analysis of the interaction between a March or September birth and the presence of HLA-DQB1*0602 for patients with moderate to severe cataplexy is presented in Table  3 . The first step revealed that both HLA-DQB1*0602 positivity and a March birth each contributed to the prediction of disease status. The addition of the interaction term in the second step did not result in a significant increase in the predictive power of the model above and beyond the individual risk factors in the first step. A similar pattern was revealed for a September birth.
DISCUSSION
In summary, the analysis of month-of-birth patterns in narcolepsy patients with cataplexy participating in two U.S. multisite clinical trials revealed a surplus in March births and a fall-off in September births relative to the general population. Both the March-birth and September-birth associations were found when cataplexy was moderate-to-severe but not when cataplexy was absent or mild. Demography and symptoms and features of narcolepsy other than cataplexy were unrelated to the month-of-birth effects with the exception that March-and September-born patients were diagnosed at an earlier age. A March birth and HLA-DQB1*0602, a genetic risk factor for narcolepsy, were found to independently predict narcolepsy with moderate-tosevere cataplexy. The surplus of March births and the fall-off in September births described here for patients with cataplexy (mild, moderate, and severe cases collectively) are of approximately the same magnitude as those reported by Dauvilliers et al. for U.S., Canadian, and French sleep center samples. 9 It is uncertain whether this birth pattern is representative of the general population of patients with narcolepsy because of the sampling bias inherent in studies of clinic samples. Different patterns may also be found in different geographic regions. A recent study conducted in Germany revealed a September trough but no prominent peak in March (a significant excess of births was reported for spring). 10 The sample however, included an unspecified number of patients without cataplexy and this may have blunted a March peak.
Discovery of season-of-birth patterns in central nervous system and autoimmune disorders has been taken as evidence that seasonally-varying environmental factors such as infectious diseases, may have etiologic importance at critical times during early development. There is strong evidence, for example, of a robust relationship between schizophrenia and birth during the winter/spring months. Exposure to a noxious environmental event, possibly an influenza virus, during the neurodevelopmentally-critical second trimester of gestation has been hypothesized to be a risk factor for schizophrenia. 19 Although there is no direct evidence, exposure to a noxious event during the second trimester may also constitute a risk factor for narcolepsy. The surplus of narcolepsy births has been specific to a single month (March) in multiple clinical cohorts suggesting a narrow window of neurodevelopmental vulnerability for this disease. A March birth would place the beginning of the second trimester near September. It is intriguing in this regard, that rhinovirus infections have been found to show sharp seasonal peaks in September or October. [20] [21] [22] [23] The present study demonstrated that cataplexy is a critical determinant of the month of birth pattern in narcolepsy. This was most evident for March births in that patients with moderate-tosevere cataplexy were more than twice as likely as controls to be born in March (17.4% vs. 8.3%) while those with no or only mild cataplexy were no more likely to be born in March than the general population. Moderate-to-severe clinician ratings are more likely when cataplexy is unambiguous and clinically-typical. 2 The current findings are consistent with the view that narcolepsy with unambiguous and clinically-typical cataplexy is a disease entity in and of itself. Alternatively, narcolepsy could also be a spectrum disorder where different risk factors can combine in a multifactorial fashion to produce more severe forms of the same underlying disease process. For example, HLA-DQB1*0602 or other unknown genetic and environmental risk factors could push an individual past an initial threshold for developing excessive daytime sleepiness and only if they are also born in March, will they pass a second threshold for developing cataplexy. 24 Just such a multifactorial model has been employed by three different groups to explain a monozygotic twin pair discordant for narcolepsy and hypocretin deficiency 25 and two monozygotic twin pairs concordant for narcolepsy but with different ages of onset. 26, 27 Mignot et al. using the same database as in the present study, found HLA-DQB1*0602 positivity to be closely linked to narcolepsy with moderate-to-severe cataplexy. 2 A weaker association was found when cataplexy was mild and an even weaker, but still significant, association was found when cataplexy was absent. It is of interest that no evidence was found here to indicate that a March birth is related to narcolepsy when cataplexy is mild or absent. It is possible that further study with larger numbers of patients with no or mild cataplexy will reveal month-ofbirth associations. On the other hand, it may be that the monthof-birth effect and DQB1*0602 reflect different causal mechanisms, with a March birth contributing only to the likelihood of narcolepsy with more severe cataplexy.
The evidence that a March birth and HLA-DQB1*0602 positivity are independent predictors of narcolepsy provides further evidence of involvement of different causal mechanisms in narcolepsy with moderate-to-severe or clear-cut cataplexy. The possibility of a March birth having a different pathophysiology is suggested by the much earlier age of diagnosis. That is, the March birth effect may result in a more severe and/or unambiguous symptomatology leading to a more straightforward and therefore earlier diagnosis. Indeed, the presence of cataplexy is a pre- dictor of an earlier diagnosis of narcolepsy. 28 In summary, exploration of month-of-birth patterns may lead to identification of risk factors and protective factors for narcolepsy. The risk for narcolepsy with clear-cut cataplexy is apparently more than doubled by a March birth suggesting that environmental factors during the prenatal or neonatal period are etiologically significant factors. As the March-birth effect may be unrelated to HLA-DQB1*0602, it could indicate a unique causal pathway. Narcolepsy with clear-cut cataplexy may be a heterogeneous disorder with subgroups defined by different combinations of environmental and or genetic factors.
